234 related articles for article (PubMed ID: 10910001)
1. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents.
Sudi KM; Gallistl S; Weinhandl G; Muntean W; Borkenstein MH
Metabolism; 2000 Jul; 49(7):890-5. PubMed ID: 10910001
[TBL] [Abstract][Full Text] [Related]
2. The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents.
Sudi KM; Gallistl S; Tröbinger M; Payerl D; Weinhandl G; Muntean W; Aigner R; Borkenstein MH
J Pediatr Endocrinol Metab; 2001 Jan; 14(1):85-94. PubMed ID: 11220710
[TBL] [Abstract][Full Text] [Related]
3. [TNF-alpha and carbohydrate and lipid parameters in overweight and obese children].
Goral J
Ann Acad Med Stetin; 2008; 54(2):14-21. PubMed ID: 19374226
[TBL] [Abstract][Full Text] [Related]
4. Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis.
Eriksson MA; Rask E; Johnson O; Carlström K; Ahrén B; Eliasson M; Boman K; Söderberg S
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):625-32. PubMed ID: 18832901
[TBL] [Abstract][Full Text] [Related]
5. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.
Estellés A; Dalmau J; Falcó C; Berbel O; Castelló R; España F; Aznar J
Thromb Haemost; 2001 Aug; 86(2):647-52. PubMed ID: 11522017
[TBL] [Abstract][Full Text] [Related]
6. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.
Kinik ST; Ozbek N; Yuce M; Yazici AC; Verdi H; Ataç FB
Thromb Haemost; 2008 Feb; 99(2):352-6. PubMed ID: 18278185
[TBL] [Abstract][Full Text] [Related]
7. Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women.
Mertens I; Van der Planken M; Corthouts B; Wauters M; Peiffer F; De Leeuw I; Van Gaal L
Horm Metab Res; 2001 Oct; 33(10):602-7. PubMed ID: 11607880
[TBL] [Abstract][Full Text] [Related]
8. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
[TBL] [Abstract][Full Text] [Related]
9. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
[TBL] [Abstract][Full Text] [Related]
10. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
12. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
13. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
Sartori MT; Vettor R; De Pergola G; De Mitrio V; Saggiorato G; Della Mea P; Patrassi GM; Lombardi AM; Fabris R; Girolami A
Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701
[TBL] [Abstract][Full Text] [Related]
14. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
Mertens I; Van der Planken M; Corthouts B; Van Gaal LF
Metabolism; 2006 May; 55(5):650-5. PubMed ID: 16631442
[TBL] [Abstract][Full Text] [Related]
15. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
van Harmelen V; Wahrenberg H; Eriksson P; Arner P
Thromb Haemost; 2000 Feb; 83(2):304-8. PubMed ID: 10739390
[TBL] [Abstract][Full Text] [Related]
16. Serum leptin in children with obesity: relationship to gender and development.
Hassink SG; Sheslow DV; de Lancey E; Opentanova I; Considine RV; Caro JF
Pediatrics; 1996 Aug; 98(2 Pt 1):201-3. PubMed ID: 8692618
[TBL] [Abstract][Full Text] [Related]
17. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.
De Mitrio V; De Pergola G; Vettor R; Marino R; Sciaraffia M; Pagano C; Scaraggi FA; Di Lorenzo L; Giorgino R
Metabolism; 1999 Aug; 48(8):960-4. PubMed ID: 10459558
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
[TBL] [Abstract][Full Text] [Related]
19. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.
Kitagawa N; Yano Y; Gabazza EC; Bruno NE; Araki R; Matsumoto K; Katsuki A; Hori Y; Nakatani K; Taguchi O; Sumida Y; Suzuki K; Adachi Y
Diabetes Res Clin Pract; 2006 Aug; 73(2):150-7. PubMed ID: 16458385
[TBL] [Abstract][Full Text] [Related]
20. Relationship between changes in plasma leptin concentrations and plasminogen activator inhibitor-1 in obese prepubertal children after nine months of treatment.
Valle Jiménez M; Martos R; Morales RM; Valle R; Cañete MD; Urbano MM; Bermudo F; Cañete R
Ann Nutr Metab; 2013; 63(3):216-22. PubMed ID: 24135306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
